Skip to main content
Quest Diagnostics

Genetic Testing Symptomatic Patients for Childhood Onset Huntington’s Disease

NSGC 2024 43rd Annual Conference

National Society of Genetic Counselors

New Orleans, LA, Sep 17-21, 2024

Poster presentation: Genetic Testing Symptomatic Patients for Childhood Onset Huntington’s Disease

Authors: Powis Z, Liaquat K, Lutz J, Meservey M, Hoffman CA, Donohue K, Batish SD

Specialty: Genetics, Neurology, Pediatrics

Related content

Conference Presentation
Expanding the Phenotype of Extremely Early Onset Juvenile Huntington’s Disease
Conference Presentation
Multiplex Detection and Quantification of Neurological Disease-Associated Repeat Expansions Using the PacBio Sequel II Platform
Audio Podcast
Patient-minded Neurology
Publication
Current State of Pediatric Reference Intervals and the Importance of Correctly Describing the Biochemistry of Child Development: A Review

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.